Menu
1 min read · estimated
APPROVED USE
What FDA approved
Adults with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase.
LAMPGEN ANALYSIS
Why it matters
The action converts a first-line chronic-phase indication originally granted accelerated approval in 2017.
What research teams should watch
Separate newly diagnosed chronic phase from resistant and advanced-phase use when coding a treatment cohort.
PRIMARY RECORDS